Back
ACADIA Pharmaceuticals Stock Price Chart
Sponsored
ACAD
Sponsored
9,530x the last time this happened
Here's what our expert says you should buy before April 14.
Sell
44
ACAD
ACADIA Pharmaceuticals
Last Price:
16.94
Seasonality Move:
17.25%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing slight selling pressure.
ACADIA Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.79 | Buy |
20-day SMA: | 17.32 | Sell |
50-day SMA: | 19.91 | Sell |
200-day SMA: | 24.47 | Sell |
8-day EMA: | 16.86 | Buy |
20-day EMA: | 17.44 | Sell |
50-day EMA: | 19.57 | Sell |
200-day EMA: | 22.69 | Sell |
ACADIA Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.86 | Sell |
Relative Strength Index (14 RSI): | 39.46 | Sell |
Chaikin Money Flow: | -593703 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.85 - 18.11) | Sell |
Bollinger Bands (100): | (18.84 - 28.44) | Sell |
ACADIA Pharmaceuticals Technical Analysis
Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for ACADIA Pharmaceuticals Stock
Is ACADIA Pharmaceuticals Stock a Buy?
- ACADIA Pharmaceuticals share price is 17.10 while ACAD 8-day simple moving average is 16.79, which is a Buy signal.
- The stock price of ACAD is 17.10 while ACADIA Pharmaceuticals 20-day SMA is 17.32, which makes it a Sell.
- ACADIA Pharmaceuticals 50-day simple moving average is 19.91 while ACAD share price is 17.10, making it a Sell technically.
- ACAD stock price is 17.10 and ACADIA Pharmaceuticals 200-day simple moving average is 24.47, creating a Sell signal.
ACAD Technical Analysis vs Fundamental Analysis
Sell
44
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy or a Sell?
-
ACADIA Pharmaceuticals stock is rated a Sell
The current ACADIA Pharmaceuticals [ACAD] share price is $17.10. The Score for ACAD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
ACADIA Pharmaceuticals Stock Info
Market Cap:
2.82B
Price in USD:
17.10
Share Volume:
1.89M
ACADIA Pharmaceuticals 52-Week Range
52-Week High:
33.99
52-Week Low:
16.16
Sell
44
ACADIA Pharmaceuticals (ACAD)
is a Sell
ACADIA Pharmaceuticals Share Price Forecast
-
What is the ACADIA Pharmaceuticals stock price today?
The ACADIA Pharmaceuticals stock price is 17.10 USD today. -
Will ACAD stock go up or go down?
ACADIA Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is ACADIA Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, ACADIA Pharmaceuticals is overvalued.
Is ACADIA Pharmaceuticals Stock a Buy?
- ACADIA Pharmaceuticals share price is 17.10 while ACAD 8-day exponential moving average is 16.86, which is a Buy signal.
- The stock price of ACAD is 17.10 while ACADIA Pharmaceuticals 20-day EMA is 17.44, which makes it a Sell.
- ACADIA Pharmaceuticals 50-day exponential moving average is 19.57 while ACAD share price is 17.10, making it a Sell technically.
- ACAD stock price is 17.10 and ACADIA Pharmaceuticals 200-day simple moving average is 22.69, creating a Sell signal.
Fundamental Analysis of ACADIA Pharmaceuticals
Is ACADIA Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.64 per share, an increase next quarter of $0.07 per share, an increase this year of $0.99 per share, and an increase next year of $0.61 per share.
Technical Analysis of ACADIA Pharmaceuticals
Should I short ACADIA Pharmaceuticals stock?
- ACAD Moving Average Covergence Divergence (MACD) indicator is -0.86, suggesting ACADIA Pharmaceuticals is a Sell
- ACADIA Pharmaceuticals Relative Strength Index (RSI) is 39.46, which suggest ACADIA Pharmaceuticals is oversold
- The Bollinger Bands (25) for ACADIA Pharmaceuticals is (16.85 - 18.11), which suggest ACADIA Pharmaceuticals is a Sell
- The Bollinger Bands (100) for ACADIA Pharmaceuticals is (18.84 - 28.44), which suggest ACADIA Pharmaceuticals is a Sell
* ACADIA Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.